课题基金 / 基金详情

Development of RNA therapies against SARS-CoV-2, other coronaviruses and influenza viruses for pandemic preparedness

Development of RNA therapies against SARS-CoV-2, other coronaviruses and influenza viruses for pandemic preparedness
开发针对 SARS-CoV-2、其他冠状病毒和流感病毒的 RNA 疗法，以预防大流行
批准号：
494284
负责人：
Gatignol Anne
金额：
$7.29万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2023
资助国家：
加拿大
项目状态：
已结题
起止时间：
2023-09-01 至 2024-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=494284&lang=en
关键词：
Antiviral Coronaviruses Influenza Viruses Innate Immunity Ppp-Rnas Sars-Cov-2 Sirnas

项目摘要

项目成果

Gatignol Anne的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Despite the availability of effective vaccines and some treatment options, SARS-CoV-2 (CoV2) -the causative agent of the COVID-19 pandemic - and its variants continue to circulate. Due to the limitations of current treatments (contraindications and reboun
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
COVID-19 Variant Supplement - Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Development of small RNAs for HIV-1 gene and drug therapy
HIV-induced modifications of the RNA interference pathway
海外基金